Breaking News Instant updates and real-time market news.

DPLO

Diplomat Pharmacy

$4.00

-0.01 (-0.25%)

, UNH

UnitedHealth

$296.39

8.46 (2.94%)

05:36
01/16/20
01/16
05:36
01/16/20
05:36

Diplomat Pharmacy downgraded to Underperform from Neutral at Credit Suisse

Credit Suisse analyst A.J. Rice downgraded Diplomat Pharmacy (DPLO) to Underperform from Neutral with an unchanged price target of $4. With the stock trading at the UnitedHealth (UNH) offer price, there is no possibility of potential upside, while there could be potential downside in the "admittedly highly unlikely" event of a deal break, Rice tells investors in a research note.

DPLO

Diplomat Pharmacy

$4.00

-0.01 (-0.25%)

UNH

UnitedHealth

$296.39

8.46 (2.94%)

DPLO Diplomat Pharmacy
$4.00

-0.01 (-0.25%)

12/09/19
RAJA
12/09/19
DOWNGRADE
RAJA
Market Perform
Diplomat Pharmacy downgraded to Market Perform from Outperform at Raymond James
Raymond James analyst John Ransom downgraded Diplomat Pharmacy (DPLO) to Market Perform from Outperform after OptumRx, the pharmacy care services business of UnitedHealth Group's (UNH) Optum, agreed to buy the company for $.00 per share in cash.
12/09/19
WBLR
12/09/19
UPGRADE
WBLR
Market Perform
Diplomat Pharmacy upgraded to Market Perform from Underperform at William Blair
William Blair analyst John Kreger upgraded Diplomat Pharmacy (DPLO) to Market Perform from Underperform after OptumRx, the pharmacy care services business of UnitedHealth Group's (UNH) Optum, agreed to buy the company for $4.00 per share in cash.
12/10/19
MZHO
12/10/19
NO CHANGE
Target $4
MZHO
Neutral
Diplomat Pharmacy unlikely to receive higher takeover bid, says Mizuho
Mizuho analyst Ann Hynes lowered her price target for Neutral-rated Diplomat Pharmacy (DPLO) to $4 from $6 to reflect UnitedHealth's (UNH) take-under buyout. The analyst does not expect any other bidders given Diplomat's outstanding debt and operational challenges. She expects the deal to be completed in January 2020.
12/10/19
DBAB
12/10/19
NO CHANGE
DBAB
Sell
Deutsche Bank does not expect another bidder for Diplomat Pharmacy
Deutsche Bank analyst George Hill does not expect another bidder to emerge for Diplomat Pharmacy (DPLO) given the "more than fair" valuation paid by UnitedHealth (UNH). The analyst, who has a Sell rating on Diplomat, also expects little regulatory pushback. Diplomat exits at 14.9 times the analyst's estimated 2020 EBITDA, which he notes is a "significant premium" to the standalone value of the company.
UNH UnitedHealth
$296.39

8.46 (2.94%)

01/08/20
CANT
01/08/20
NO CHANGE
Target $35
CANT
Overweight
Amarin headline related to UnitedHealth 'just noise,' says Cantor Fitzgerald
Cantor Fitzgerald analyst Louise Chen said she believes the 5% pullback in Amarin (AMRN) shares is related to headlines that there is a document that says Vascepa has been deemed by UnitedHealth (UNH) to be a "non-preferred" drug that requires prior authorization. However she said the drugmaker confirmed that "this is old news" since UnitedHealth has always been an outlier. If anything, she believes the reimbursement situation with UnitedHealth "could get better quickly" now that Vascepa has a broad label and she views the pullback amid this "noise" could be a good buying opportunity. Chen maintains an Overweight rating and $35 price target on Amarin shares.
01/08/20
SBSH
01/08/20
NO CHANGE
SBSH
Neutral
Amarin selloff on UnitedHealth preferred list reports unwarranted, says Citi
Citi analyst Joel Beatty attributes the selloff today in shares of Amarin (AMRN) to reports stating that UnitedHealth (UNH) dropped Vascepa from its preferred list for 2020. However, after comparing 2019 and 2020 documents for a few UnitedHealth plans, Beatty did not find any examples of changes in tiering or other preferential status for Vascepa. Payers likely haven't yet considered the new "game-changing" cardiovascular risk-reduction label for Vascepa that was granted in December, which leaves Vascepa with no relevant competitors, Beatty tells investors in an intraday research note. As a result, the analyst, who keeps a Neutral rating on Amarin, views today's share pullback as unwarranted. The move creates a lower entry point for those investors looking to buy the stock, says Beatty. Amarin in afternoon trading is down 6%, or $1.15, to $18.93.
01/09/20
ROTH
01/09/20
NO CHANGE
Target $31
ROTH
Buy
Payers 'just need time' to update formularies for Amarin's Vascepa, Roth says
Following yesterday's speculation regarding UnitedHealth's (UNH) reimbursement of Amarin's (AMRN) Vascepa, Roth Capital analyst Yasmeen Rahimi believes payers "just need time to absorb label expansion to update formularies." Although Amarin communicated Vascepa's new label to all major payers within 24 hours of the recent approval, label expansion occurred barely four weeks ago and many payers are digesting specifics of the new label and how it impacts coverage, Rahimi tells investors in a research note tiled "World's the Oyster in 2020 for Vascepa." The analyst also notes that Amarin, per the company's management, already has meetings scheduled in Q1 with some of the largest national payers, "which should allow for productive dialogue especially around prior authorizations." Rahimi sees "strong supporting evidence" indicating that reimbursement and coverage will only improve given the new cardiovascular risk reduction label for Vascepa. With a "broad label" in Canada that looks similar to the FDA approval, Amarin is positioned for "strong partnership interest" in Europe and the remaining geographies, contends the analyst. Rahimi says the company's continued news flow in early 2020, especially around approval of Vascepa by Health Canada and this week's "continued strong" guidance update, marks strong execution by the management team. The analyst keeps a Buy rating on the shares with a $31 price target. Amarin in morning trading is up 70c to $20.16.
01/15/20
SPHN
01/15/20
NO CHANGE
Target $333
SPHN
Overweight
UnitedHealth price target raised to $333 after earnings at Stephens
Stephens analyst Scott Fidel raised his 2020-2022 adjusted EPS estimates for UnitedHealth and increased his price target for the stock to $333 from $325 after the company reported what he called "a solid beat on a better-than-expected MLR" in the fourth quarter. Medicaid was a laggard for UnitedHealth in 2018-2019, but the company said it saw positive traction in Q4 and Fidel believes underlying trends in that area appear to be improving, while the company's tone on MA growth was "very optimistic," he tells investors. He maintains an Overweight rating on UnitedHealth shares.

TODAY'S FREE FLY STORIES

FBMS

First Bancshares

$33.70

-0.4 (-1.17%)

20:54
01/21/20
01/21
20:54
01/21/20
20:54
Hot Stocks
First Bancshares raises quarterly dividend to 10c from 8c per share »

The dividend is payable…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FBMS

First Bancshares

$33.70

-0.4 (-1.17%)

20:54
01/21/20
01/21
20:54
01/21/20
20:54
Earnings
First Bancshares reports Q4 EPS 72c, consensus 74c »

Reports Q4 NII $33.8M vs.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NNVC

NanoViricides

$8.10

4.76 (142.51%)

20:39
01/21/20
01/21
20:39
01/21/20
20:39
Syndicate
NanoViricides 2.5M share Secondary priced at $3.00 »

Aegis is acting as sole…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ABT

Abbott

$89.76

0.76 (0.85%)

, BKR

Baker Hughes

$22.72

-0.9 (-3.81%)

20:25
01/21/20
01/21
20:25
01/21/20
20:25
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

ABT

Abbott

$89.76

0.76 (0.85%)

BKR

Baker Hughes

$22.72

-0.9 (-3.81%)

ALLY

Ally Financial

$30.25

-0.19 (-0.62%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

  • 22

    Jan

  • 22

    Jan

  • 23

    Mar

MDT

Medtronic

$120.30

1.32 (1.11%)

20:03
01/21/20
01/21
20:03
01/21/20
20:03
Recommendations
Medtronic analyst commentary  »

Medtronic price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 24

    Jan

  • 18

    Feb

CNC

Centene

$65.48

0.96 (1.49%)

, WCG

WellCare

$340.52

3.55 (1.05%)

19:49
01/21/20
01/21
19:49
01/21/20
19:49
Hot Stocks
WellCare, Centene satisfy merger requirements »

Centene (CNC) and…

CNC

Centene

$65.48

0.96 (1.49%)

WCG

WellCare

$340.52

3.55 (1.05%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Feb

  • 13

    Feb

AAPL

Apple

$316.39

-2.27 (-0.71%)

, HNHPF

Hon Hai Precision

$0.00

(0.00%)

19:17
01/21/20
01/21
19:17
01/21/20
19:17
Periodicals
Apple suppliers to start making new low-cost iPhone in February, Bloomberg says »

Apple (AAPL) suppliers…

AAPL

Apple

$316.39

-2.27 (-0.71%)

HNHPF

Hon Hai Precision

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jan

EFC

Ellington Financial

$18.85

0.13 (0.69%)

19:12
01/21/20
01/21
19:12
01/21/20
19:12
Syndicate
Ellington Financial 4.6M share Spot Secondary priced at $18.29 »

Morgan Stanley, Credit…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

MRVSY

Minerva SA

$0.00

(0.00%)

18:59
01/21/20
01/21
18:59
01/21/20
18:59
Downgrade
Minerva SA rating change at Goldman Sachs »

Minerva SA downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GRPBF

Grupo Lala

$0.00

(0.00%)

18:57
01/21/20
01/21
18:57
01/21/20
18:57
Downgrade
Grupo Lala rating change at Goldman Sachs »

Grupo Lala downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CCU

Compania Cervecerias

$19.00

-0.33 (-1.71%)

18:53
01/21/20
01/21
18:53
01/21/20
18:53
Downgrade
Compania Cervecerias rating change at Goldman Sachs »

Compania Cervecerias…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GRPBF

Grupo Lala

$0.00

(0.00%)

18:50
01/21/20
01/21
18:50
01/21/20
18:50
Upgrade
Grupo Lala rating change at Goldman Sachs »

Grupo Lala upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GPAGF

Gruma

$0.00

(0.00%)

18:48
01/21/20
01/21
18:48
01/21/20
18:48
Upgrade
Gruma rating change at Goldman Sachs »

Gruma upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KOF

Coca-Cola Femsa

$62.52

0.41 (0.66%)

18:47
01/21/20
01/21
18:47
01/21/20
18:47
Upgrade
Coca-Cola Femsa rating change at Goldman Sachs »

Coca-Cola Femsa upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LOGI

Logitech

$47.77

1.2 (2.58%)

18:46
01/21/20
01/21
18:46
01/21/20
18:46
Hot Stocks
Logitech CEO: We're growing all three of our businesses at a healthy clip »

In an interview on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Jan

NAVI

Navient

$13.86

-0.01 (-0.07%)

, IBM

IBM

$139.15

0.84 (0.61%)

18:44
01/21/20
01/21
18:44
01/21/20
18:44
Hot Stocks
Fly Intel: After Hours Movers »

UP AFTER EARNINGS:…

NAVI

Navient

$13.86

-0.01 (-0.07%)

IBM

IBM

$139.15

0.84 (0.61%)

COF

Capital One

$102.29

-1.85 (-1.78%)

FBK

FB Financial

$38.20

-0.66 (-1.70%)

NFLX

Netflix

$338.24

-1.32 (-0.39%)

MNLO

Menlo Therapeutics

$6.48

-0.17 (-2.56%)

CIT

CIT Group

$45.23

-1.17 (-2.52%)

SKT

Tanger Factory

$15.93

0.56 (3.64%)

ETN

Eaton

$94.51

-1.19 (-1.24%)

SUPN

Supernus

$24.70

0.26 (1.06%)

ZION

Zions Bancorp

$49.93

-0.81 (-1.60%)

IBKR

Interactive Brokers

$50.89

0.7 (1.39%)

AMTD

TD Ameritrade

$50.76

0.25 (0.49%)

FULT

Fulton Financial

$17.26

-0.07 (-0.40%)

UAL

United Airlines

$85.84

-3.84 (-4.28%)

ADAP

Adaptimmune

$4.14

-0.38 (-8.41%)

BPMC

Blueprint Medicines

$79.69

-1.46 (-1.80%)

ELAN

Elanco

$30.64

0.65 (2.17%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Jan

  • 21

    Jan

  • 21

    Jan

  • 21

    Jan

  • 21

    Jan

  • 21

    Jan

  • 21

    Jan

  • 22

    Jan

  • 22

    Jan

  • 22

    Jan

  • 22

    Jan

  • 28

    Jan

  • 04

    Feb

  • 06

    Feb

  • 06

    Feb

  • 14

    Feb

  • 19

    Feb

  • 26

    Feb

  • 22

    Jan

  • 23

    Jan

  • 23

    Jan

SUPN

Supernus

$24.70

0.26 (1.06%)

18:35
01/21/20
01/21
18:35
01/21/20
18:35
Hot Stocks
Supernus: FDA accepts for review NDA for SPN-812 »

Supernus announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NFLX

Netflix

$338.24

-1.32 (-0.39%)

18:31
01/21/20
01/21
18:31
01/21/20
18:31
Hot Stocks
Netflix says doesn't want to 'exploit' users with advertising »

Says mobile-only plans in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Jan

COST

Costco

$313.28

8.6 (2.82%)

18:25
01/21/20
01/21
18:25
01/21/20
18:25
Hot Stocks
Costco CEO: We're a volume company, not a margin company »

In an interview on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

  • 05

    Mar

NFLX

Netflix

$338.24

-1.32 (-0.39%)

18:24
01/21/20
01/21
18:24
01/21/20
18:24
Hot Stocks
Netflix says plans to increase content spending across the board »

Says plans to increase…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Jan

PBR

Petrobras

$14.76

-0.41 (-2.70%)

18:23
01/21/20
01/21
18:23
01/21/20
18:23
Hot Stocks
Petrobras says CARF issued 'unfavorable' decision on tax proceeding »

Petrobras said that the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FMBI

First Midwest

$21.58

-0.725 (-3.25%)

18:15
01/21/20
01/21
18:15
01/21/20
18:15
Earnings
First Midwest reports Q4 EPS 51c, consensus 50c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

NFLX

Netflix

$338.24

-1.32 (-0.39%)

, DIS

Disney

$143.53

-0.72 (-0.50%)

18:14
01/21/20
01/21
18:14
01/21/20
18:14
Hot Stocks
Netflix says Oscar-nominated original films 'very popular' with users as well »

Netflix (NFLX) says…

NFLX

Netflix

$338.24

-1.32 (-0.39%)

DIS

Disney

$143.53

-0.72 (-0.50%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Jan

  • 04

    Feb

MDT

Medtronic

$120.30

1.32 (1.11%)

18:12
01/21/20
01/21
18:12
01/21/20
18:12
Hot Stocks
Medtronic: Trial shows 'superior' back pain relief with DTM SCS »

Medtronic announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 18

    Feb

NFLX

Netflix

$338.24

-1.32 (-0.39%)

, DIS

Disney

$143.53

-0.72 (-0.50%)

18:07
01/21/20
01/21
18:07
01/21/20
18:07
Hot Stocks
Netflix says seasonality from Q1 to Q2 likely to be 'more balanced' »

Netflix (NFLX) says Q1…

NFLX

Netflix

$338.24

-1.32 (-0.39%)

DIS

Disney

$143.53

-0.72 (-0.50%)

GOOG

Alphabet

$1,484.92

4.64 (0.31%)

GOOGL

Alphabet Class A

$1,482.70

3.58 (0.24%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Jan

  • 22

    Jan

  • 22

    Jan

  • 23

    Jan

  • 27

    Jan

  • 03

    Feb

  • 03

    Feb

  • 04

    Feb

  • 10

    Feb

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.